Efficacy and Safety of Hexaminolevulinate Fluorescence Cystoscopy in the Diagnosis of Bladder Cancer
Open Access
- 1 January 2012
- journal article
- Published by The Korean Urological Association in Korean Journal of Urology
- Vol. 53 (12) , 821-825
Abstract
Lee JS, et al. Korean J Urol. 2012 Dec;53(12):821-825. https://doi.org/10.4111/kju.2012.53.12.821Keywords
This publication has 21 references indexed in Scilit:
- EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 UpdateEuropean Urology, 2011
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- LONG-TERM BENEFIT OF 5-AMINOLEVULINIC ACID FLUORESCENCE ASSISTED TRANSURETHRAL RESECTION OF SUPERFICIAL BLADDER CANCER: 5-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED STUDYJournal of Urology, 2005
- IMPROVED DETECTION AND TREATMENT OF BLADDER CANCER USING HEXAMINOLEVULINATE IMAGING: A PROSPECTIVE, PHASE III MULTICENTER STUDYJournal of Urology, 2005
- Comparison of Hexaminolevulinate Based Flexible and Rigid Fluorescence Cystoscopy with Rigid White Light Cystoscopy in Bladder Cancer: Results of a Prospective Phase II StudyEuropean Urology, 2005
- Fluorescence Cystoscopy in the Management of Bladder Cancer: A Help for the Urologist!Urologia Internationalis, 2005
- A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?European Urology, 2004
- Hexyl Aminolevulinate Fluorescence Cystoscopy: A New Diagnostic Tool for Photodiagnosis of Superficial Bladder Cancer—A multicenter studyJournal of Urology, 2003
- Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin FluorescenceJournal of Urology, 1996
- Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin FluorescenceJournal of Urology, 1996